Potencial Analítico de los Polímeros de Impronta Molecular (MIPs) como Elementos de Reconocimiento Biomimético

Los polímeros de impronta molecular (MIPs) son materiales sintéticos que presentan propiedades de reconocimiento molecular específico hacia determinados compuestos. Estos materiales con “memoria selectiva” presentan un elevado potencial analítico como sustitutos de elementos de reconocimiento de origen biológico para el desarrollo de sensores, como sorbentes en procesos de extracción en fase sólida (SPE) y como fases estacionarias para HPLC y CE. La síntesis de estos materiales se basa en la formación de una estructura polimérica, altamente entrecruzada, alrededor de una molécula que actúa como plantilla que se extrae después de la polimerización. De esta forma, el MIP contendrá sitios de unión que son complementarios a la molécula plantilla en forma, tamaño y distribución de grupos funcionales que permiten su reconocimiento posterior, de forma selectiva Los MIPs suelen presentar ventajas interesantes en comparación con los receptore

Biophotonic Sensing Cells (BICELLs) for label-free biosensing

Label free immunoassay sector is a ferment of activity, experiencing rapid growth as new technologies come forward and achieve acceptance. The landscape is changing in a “bottom up” approach, as individual companies promote individual technologies and find a market for them. Therefore, each of the companies operating in the label-free immunoassay sector offers a technology that is in some way unique and proprietary. However, no many technologies based on Label-free technology are currently in the market for PoC and High Throughput Screening (HTS), where mature labeled technologies have taken the market

Dengue in Madeira Island

This is a preprint of a paper whose final and definite form will be published in the volume Mathematics of Planet Earth that initiates the book series CIM Series in Mathematical Sciences (CIM-MS) published by Springer. Submitted Oct/2013; Revised 16/July/2014 and 20/Sept/2014; Accepted 28/Sept/2014.Dengue is a vector-borne disease and 40% of world population is at risk. Dengue transcends international borders and can be found in tropical and subtropical regions around the world, predominantly in urban and semi-urban areas. A model for dengue disease transmission, composed by mutually-exclusive compartments representing the human and vector dynamics, is presented in this study. The data is from Madeira, a Portuguese island, where an unprecedented outbreak was detected on October 2012. The aim of this work is to simulate the repercussions of the control measures in the fight of the disease

Biophotonic Sensing Cells Optimization for label-free biosensing

Los sectores de detección biológica demandan continuamente técnicas de análisis y diagnóstico más eficientes y precisas para identificar enfermedades y desarrollar nuevos medicamentos. Actualmente se considera que hay una gran necesidad de desarrollar herramientas de diagnóstico capaces de asegurar sensibilidad, rapidez, sencillez y asequibilidad para aplicaciones en sectores como la salud, la alimentación, el medioambiente o la seguridad. En el ámbito clínico se necesitan profundos avances tecnológicos capaces de ofrecer análisis rápidos, exactos, fiables y asequibles en coste y que tengan como consecuencia la mejora clínica y económica a partir de un diagnóstico eficiente. En concreto, hay un interés creciente por la descentralización del diagnóstico clínico mediante plataformas de detección cercanas al usuario final, denominadas POCs (Point Of Care devices). La utilización de POCs (referidas al diagnóstico cercano al usuario final o fuera del laboratorio de análisis clínico), mediante detección in vitro (IVD), será extremadamente útil en centros de salud, clínicas o unidades hospitalarias, entornos laborales o incluso en el hogar. Por otra parte, el desarrollo de la genómica, proteómica y otras tecnologías conocidas como “omics” (sufijo en inglés para referirse, por ejemplo, a genomics, transcriptomics, proteomics, metabolomics, lipidomics) está incrementando la demanda de nuevas tecnologías mucho más avanzadas con una clara orientación hacia la medicina personalizada y la necesidad de hacer frente a cambios en los tratamientos en el caso de enfermedades complejas. Desde hace poco tiempo se han definido las Celdas Biofónicas (BICELLs) como una metodología novedosa para la detección de agentes biológicos que ofrecen una serie de características que las hacen interesantes como son: Capacidad de multiplexación, alta sensibilidad, posibilidad de medir en gota, compatible con otras tecnologías. En este trabajo se hace un estudio y optimización sobre diferentes tipos de BICELLs y se valoran una serie de figuras de merito a tener en cuenta desde el punto de vista del lector óptico a emplear

Nanoscale waveguiding methods

While 32 nm lithography technology is on the horizon for integrated circuit (IC) fabrication, matching the pace for miniaturization with optics has been hampered by the diffraction limit. However, development of nanoscale components and guiding methods is burgeoning through advances in fabrication techniques and materials processing. As waveguiding presents the fundamental issue and cornerstone for ultra-high density photonic ICs, we examine the current state of methods in the field. Namely, plasmonic, metal slot and negative dielectric based waveguides as well as a few sub-micrometer techniques such as nanoribbons, high-index contrast and photonic crystals waveguides are investigated in terms of construction, transmission, and limitations. Furthermore, we discuss in detail quantum dot (QD) arrays as a gain-enabled and flexible means to transmit energy through straight paths and sharp bends. Modeling, fabrication and test results are provided and show that the QD waveguide may be effective as an alternate means to transfer light on sub-diffraction dimensions

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems

Plasma lipid profiles discriminate bacterial from viral infection in febrile children

Fever is the most common reason that children present to Emergency Departments. Clinical signs and symptoms suggestive of bacterial infection are often non-specific, and there is no definitive test for the accurate diagnosis of infection. The 'omics' approaches to identifying biomarkers from the host-response to bacterial infection are promising. In this study, lipidomic analysis was carried out with plasma samples obtained from febrile children with confirmed bacterial infection (n = 20) and confirmed viral infection (n = 20). We show for the first time that bacterial and viral infection produces distinct profile in the host lipidome. Some species of glycerophosphoinositol, sphingomyelin, lysophosphatidylcholine and cholesterol sulfate were higher in the confirmed virus infected group, while some species of fatty acids, glycerophosphocholine, glycerophosphoserine, lactosylceramide and bilirubin were lower in the confirmed virus infected group when compared with confirmed bacterial infected group. A combination of three lipids achieved an area under the receiver operating characteristic (ROC) curve of 0.911 (95% CI 0.81 to 0.98). This pilot study demonstrates the potential of metabolic biomarkers to assist clinicians in distinguishing bacterial from viral infection in febrile children, to facilitate effective clinical management and to the limit inappropriate use of antibiotics